You are here: Industry Insights > narcolepsy

News List

Glenmark Pharma gets USFDA approval for Amphetamine Sulfate Tablets expresspharma
January 28, 2021
The tablets are used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy, a sleeping disorder.
GSK says science does not link pandemic H1N1 flu vaccine to sleep disorder expresspharma
May 29, 2020
A spokesman for GSK said the “science has moved on” since concerns were raised about links between narcolepsy and its H1N1 vaccine, called Pandemrix, which was developed during the flu pandemic 10 years ago.
FDA Approves Wakix (pitolisant), a First-in-Class Medication for the Treatment of Excessive Daytime Sleepiness in Adult Patients with Narcolepsy drugs
August 16, 2019
Harmony Biosciences, LLC (Harmony) announced today that the U.S. Food and Drug Administration (FDA) approved Wakix (pitolisant) for the treatment of excessive daytime sleepiness (EDS) in adult patients with narcolepsy.
FDA grants Orphan Drug Designation for narcolepsy treatment europeanpharmaceuticalreview
June 27, 2019
The FDA has given the XWL-008 compound Orphan Drug Designation for the treatment of narcolepsy.
Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea drugs
December 24, 2018
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for its new drug application (NDA) for .......
XW Labs Initiates First-in-Human Phase I Study for Novel Narcolepsy Treatment prnasia
March 13, 2018
XW Labs Announces First Single-Step Incremental Dosing (SAD) Study in Australian Healthy Subjects